Emerging Tumor Marker Diagnostic Technologies, and Strategic Profiles of Leading Suppliers 2015 - A Review of Competing/Complementing Technologies

Aug 17, 2015, 12:10 ET from Research and Markets

DUBLIN, Aug. 17, 2015 /PRNewswire/ --

Research and Markets(http://www.researchandmarkets.com/research/kt7dkm/2015_emerging) has announced the addition of the "2015 Emerging Tumor Marker Diagnostic Technologies, and Strategic Profiles of Leading Suppliers" report to their offering.

This 185-page report provides detailed assessments of such technologies as monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for tumor markers technologies.

Also included is a review of competing/complementing technologies, such as CT, MRI, NMR, PET and photonics spectroscopy.

The report also presents strategic assessments of current and emerging suppliers of tumor marker diagnostic products, including their sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. 

For more information visit http://www.researchandmarkets.com/research/kt7dkm/2015_emerging

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

SOURCE Research and Markets



RELATED LINKS

http://www.researchandmarkets.com